Drug Trial Radar · NCT05289557
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Last checked: Nov 19, 2026Latest source record: Apr 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
274
Planned (sponsor's estimate)
Start
May 1, 2022
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Duchesnay Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Premier Research
- First posted
- Mar 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 12 years, up to 17 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to compare the efficacy of Bonjesta for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Bonjesta in pregnant adolescents aged 12 to 17 years with placebo.
Conditions
- Morning Sickness
Interventions
BonjestaDrug
Extended-release tablets contain 20 mg of doxylamine succinate and 20 mg of pyridoxine hydrochloride. Minimum 1 tablet at bedtime. Up to two pills daily (one tablet in the morning and one tablet at bedtime). The treatment duration is 15 days.
PlaceboDrug
Sugar pills with no active ingredients. Minimum 1 tablet at bedtime. Up to two pills daily (one tablet in the morning and one tablet at bedtime). The treatment duration is 15 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Nausea and Vomiting of Pregnancy Severity from Baseline to Day 15Time frame: Day 1-Day 15
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Velvet Clinical Research
Burbank, California
Vital Pharma Research
Hialeah, Florida
New Horizon Research Center
Miami, Florida
Emerald Coast OB/GYN Clinical Research
Panama City, Florida
Clinical Research Prime
Idaho Falls, Idaho
Unified Women's Clinical Research
Winston-Salem, North Carolina
Clinovacare Medical Research Center
West Columbia, South Carolina
Maximos OBGYN
League City, Texas
Axon Clinical Research
Mesquite, Texas
Advances in Health
Pearland, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.